JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB228885

Anti-CBP80 antibody - N-terminal

Be the first to review this product! Submit a review

|

(1 Publication)

Rabbit Polyclonal CBP80 antibody. N-terminal. Suitable for WB, IHC-P, ICC/IF and reacts with Human, Mouse samples. Cited in 1 publication. Immunogen corresponding to Recombinant Fragment Protein within Human NCBP1.

View Alternative Names

CBP80, NCBP, NCBP1, Nuclear cap-binding protein subunit 1, 80 kDa nuclear cap-binding protein, NCBP 80 kDa subunit

3 Images
Immunocytochemistry/ Immunofluorescence - Anti-CBP80 antibody - N-terminal (AB228885)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-CBP80 antibody - N-terminal (AB228885)

Paraformaldehyde-fixed HeLa (human epithelial cell line from cervix adenocarcinoma) cells stained for CBP80 (green) using ab228885 at 1/200 dilution in ICC/IF.

Nuclear counterstain : Hoechst 33342 (blue)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CBP80 antibody - N-terminal (AB228885)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CBP80 antibody - N-terminal (AB228885)

Paraffin-embedded mouse fore brain tissue stained for CBP80 using ab228885 at 1/500 dilution in immunohistochemical analysis.

Western blot - Anti-CBP80 antibody - N-terminal (AB228885)
  • WB

Supplier Data

Western blot - Anti-CBP80 antibody - N-terminal (AB228885)

7.5% SDS-PAGE gel.

All lanes:

Western blot - Anti-CBP80 antibody - N-terminal (ab228885) at 1/1000 dilution

All lanes:

HeLa (human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 30 µg

Predicted band size: 92 kDa

true

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Human

Applications

WB, IHC-P, ICC/IF

applications

Immunogen

Recombinant Fragment Protein within Human NCBP1. The exact immunogen used to generate this antibody is proprietary information.

Q09161

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/500 - 1/3000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "guaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/100 - 1/1000", "ICCIF-species-notes": "<p></p>" }, "Mouse": { "WB-species-checked": "guaranteed", "WB-species-dilution-info": "", "WB-species-notes": "", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/100 - 1/1000", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Rat": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Chicken": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Storage buffer
pH: 7 Preservative: 0.01% Thimerosal (merthiolate) Constituents: 20% Glycerol (glycerin, glycerine), 1.21% Tris, 0.75% Glycine
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

CBP80 also known as cap-binding protein 80 is an important component of the cap-binding complex (CBC) with a mass of about 80 kDa. This protein primarily binds to the 5' cap structure of newly synthesized pre-mRNA in eukaryotic cells. CBP80 often associates with CBP20 and together they form the CBC. It facilitates the processing of pre-mRNA and is mainly expressed in the nucleus of cells. CBP80 is integral in stabilizing RNA transcripts during their maturation.
Biological function summary

CBP80 plays a role in the initiation of mRNA processing events. As a part of the CBC it influences RNA splicing export and translation initiation. It participates in early mRNA export from the nucleus to the cytoplasm and is essential in quality control mechanisms that ensure accurate mRNA translation. The CBP80-CBP20 complex also impacts nonsense-mediated mRNA decay (NMD) a process that degrades faulty mRNAs preventing the production of truncated proteins.

Pathways

CBP80 integrates into the mRNA surveillance pathway where it works closely with other key proteins such as UPF1 UPF2 and UPF3 in the NMD pathway. These interactions ensure erroneous mRNA is efficiently targeted and degraded. Additionally CBP80 plays a minor role in the pathway of general mRNA export where it cooperates with export factors like CRM1. Its involvement in these pathways highlights its role in maintaining the fidelity of gene expression.

CBP80's malfunction has been linked to certain cancer types and neurodevelopmental disorders. Altered activity of CBP80 can lead to the accumulation of aberrant mRNA transcripts which contributes to oncogenesis. In some neurodevelopmental disorders mutations affecting CBP80 or its interacting partner CBP20 can disrupt normal neural development. This suggests that CBP80 not only maintains normal cell function but also prevents the development of disease through its regulation of gene expression.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Component of the cap-binding complex (CBC), which binds cotranscriptionally to the 5'-cap of pre-mRNAs and is involved in various processes such as pre-mRNA splicing, translation regulation, nonsense-mediated mRNA decay, RNA-mediated gene silencing (RNAi) by microRNAs (miRNAs) and mRNA export. The CBC complex is involved in mRNA export from the nucleus via its interaction with ALYREF/THOC4/ALY, leading to the recruitment of the mRNA export machinery to the 5'-end of mRNA and to mRNA export in a 5' to 3' direction through the nuclear pore. The CBC complex is also involved in mediating U snRNA and intronless mRNAs export from the nucleus. The CBC complex is essential for a pioneer round of mRNA translation, before steady state translation when the CBC complex is replaced by cytoplasmic cap-binding protein eIF4E. The pioneer round of mRNA translation mediated by the CBC complex plays a central role in nonsense-mediated mRNA decay (NMD), NMD only taking place in mRNAs bound to the CBC complex, but not on eIF4E-bound mRNAs. The CBC complex enhances NMD in mRNAs containing at least one exon-junction complex (EJC) via its interaction with UPF1, promoting the interaction between UPF1 and UPF2. The CBC complex is also involved in 'failsafe' NMD, which is independent of the EJC complex, while it does not participate in Staufen-mediated mRNA decay (SMD). During cell proliferation, the CBC complex is also involved in microRNAs (miRNAs) biogenesis via its interaction with SRRT/ARS2 and is required for miRNA-mediated RNA interference. The CBC complex also acts as a negative regulator of PARN, thereby acting as an inhibitor of mRNA deadenylation. In the CBC complex, NCBP1/CBP80 does not bind directly capped RNAs (m7GpppG-capped RNA) but is required to stabilize the movement of the N-terminal loop of NCBP2/CBP20 and lock the CBC into a high affinity cap-binding state with the cap structure. Associates with NCBP3 to form an alternative cap-binding complex (CBC) which plays a key role in mRNA export and is particularly important in cellular stress situations such as virus infections. The conventional CBC with NCBP2 binds both small nuclear RNA (snRNA) and messenger (mRNA) and is involved in their export from the nucleus whereas the alternative CBC with NCBP3 does not bind snRNA and associates only with mRNA thereby playing a role only in mRNA export. NCBP1/CBP80 is required for cell growth and viability (PubMed : 26382858).
See full target information NCBP1

Publications (1)

Recent publications for all applications. Explore the full list and refine your search

Frontiers in cardiovascular medicine 9:1062695 PubMed36568562

2022

Large-conductance Ca-activated K channel β1-subunit maintains the contractile phenotype of vascular smooth muscle cells.

Applications

Unspecified application

Species

Unspecified reactive species

Meili Wang,Shuanglei Li,Hongshan Liu,Mingyuan Liu,Jin Zhang,Yang Wu,Cangsong Xiao,Haixia Huang
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com